Reactive PEGs,Block Copolymers,Fatty Acid Chain For Anti-diabetic Drug

Service

PEG Chemistry

· PEGylation and conjugation chemistry · Characterization of proteins Preliminary Phase 1. Feasibility study. 2. Screening study to optimize pegylation conditions. 3. Pegylation product separation and purification. 4. Pegylation product cha...
Find Out More
Analytical Chemistry

· Compounds, analysis and purification · PEG impurity profiling
Find Out More
Advanced Drug Delivery Systems (DDS)

Block copolymers and proof-of-concept for uses in DDS
Find Out More
Synthetic Organic Chemistry

· Multi-step synthesis skills (10~15 Steps), Heterocyclic compounds, Choral chemistry
Find Out More

Collaboration & Partner

SINOPEG's vision is be an science company, providing innovative materi-als and technology to partner with our customers on current treatment improvement and new therapeutics development for improved patient treatment quality and better human health.

Find Out More

Latest News

Introducing XcellFect RNA Transfection Reagent: Revolutionize Your RNA Delivery with Unmatched Efficiency & Simplicity!

Product Name: XcellFect RNA Transfection Reagent Catalog No.: D7010101 Storage: Sealed at 4°C. Avoid repeated freeze-thaw cycles. Why Choose XcellFect? High Efficiency, Low Toxicity: Powered by our patented lipid-based formulation, XcellFect overcome...
Riding the Waves, Connecting Globally | Dual Exhibitions, SINOPEG Shines in Europe!

This golden autumn, SINOPEG ventured to Europe with its innovative products and solutions, making consecutive appearances at two premier international industry exhibitions within two months, engaging in deep exchanges with global pharmaceutical elite...
SINOPEG's mPEG-DTA-1 and HO-PEG-DTA-5 Granted European Patents, Domestically Developed High-End LNP Excipients Gain International Recognition

Recently, SINOPEG's self-developed products, mPEG-DTA-1 and HO-PEG-DTA-5, have been formally granted European patents! This marks the recognition of domestically produced high-end LNP excipients by the international regulatory system, laying a solid ...

SINOPEG is a dynamic science company dedicated to drug delivery systems (DDS). As a leading company in polyethylene glycol derivatives (PEGs), we are also specialized in the R&D of long acting biopharmaceuticals, developing and manufacturing of block copolymers, lipids for drug delivery, medical devices, bio-engineering, and other broad uses.

About Us

SINOPEG is dedicated to drug delivery systems and related medical device business, focusing on the research, development, production and sales of high-end drug delivery carriers/auxiliary materials/APIs, medical materials, including but not limited to polyethylene glycol derivatives, lipid products, blood sugar control drug modifiers, block copolymers, ADC/ProTAC linkers, biodegradable polymers, exosomes, viral-like particles, as well as providing CDMO and solution services. These products are widely used in long-acting protein/peptide drugs, mRNA vaccines, small nucleic acid drugs, blood sugar control drugs, macromolecular micelle drugs...

Find Out More

Our Vision
SINOPEG’s vision is to be an science company, providing innovative materials and technology to partner with our customers
Our Mission
SINOPEG partners with our customers and collaborators to create value through:Provide innovative products to enable technolog
Our Advantage
SINOPEG has 24+ patents on PEG Derivatives and Pegylated Drugs ISO-9001 and ISO-13485 certified.
Customization
SINOPEG is able to customize a wide range of PEG products from mg to kg, and our products can meet the specific requirements of customers